BERLIN and SEATTLE, April 11, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a cancer molecular diagnostics company developing tests based on DNA methylation, will present the most recent data from its colorectal cancer screening test development program at the upcoming Annual Meeting 2007 of the American Association for Cancer Research (AACR) in Los Angles, CA, U.S.A.
